Pharma Focus Asia
KP - Choose our fully recyclable blister films

Specialised Therapeutics Acquires Commercialisation Rights for New Motor Neuron Disease Therapy

Monday, August 28, 2023

Specialised Therapeutics has recently announced a collaboration with Treeway to bring a new therapy TW001 to Australia and New Zealand for the treatment of Amyotrophic Lateral Sclerosis (ALS), which is the most common form of Motor Neurone Disease (MND).

Under the terms of agreement, Specialised Therapeutics takes charge of various aspects such as marketing, regulatory processes, and distribution of TW001 for ALS/MND in Australia and New Zealand.

TW001, the innovative therapy, is an oral formulation of edaravone. Its mechanism of action involves reducing the oxidative damage that contributes to the death of neurons in ALS. Currently, TW001 is undergoing evaluation in a crucial phase III clinical trial called ADORE, being conducted at nearly 40 global sites.

Amyotrophic Lateral Sclerosis (ALS) is a prevalent motor neuron disease marked by the progressive degeneration of motor neurons in the spinal cord and brain. This degeneration leads to gradual paralysis, often resulting in death within 2 to 5 years after diagnosis.

ALS is relatively rare disease affecting individuals aged between 40 to 70, with slightly more cases occurring in men than in women. While 10-15 percent of cases have a genetic or familial link, the remaining 85-90 percent are classified as sporadic cases, where the exact cause is not yet known.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoBora Pharmaceuticals - Free WhitepaperThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023
MasterControl - 6 Essential Features in an eQMS